the role of neoadjuvant immunotherapy in msi-high gastric cancer
Published 1 year ago • 321 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
1:25
neoadjuvant immunotherapy in msi-high colorectal cancer
-
2:56
perioperative immunotherapy and surgery for treating msi-high esophagogastric tumors
-
2:09
evaluating the optimal approach for managing msi-h upper gi cancers
-
0:50
the evolving role of surgery after neoadjuvant immunotherapy in melanoma
-
5:00
surgical advances in in gastric and gej cancer
-
2:12
clinical trials investigating immunotherapy for gastric cancer
-
0:35
gastrointestinal cancer trials to watch out for in 2023
-
3:32
bintrafusp alfa in msi-h cancers following progression on immunotherapy
-
1:00
evaluating the emerging role of cellular therapies in gi cancers
-
1:37
microsatellite instability screening in gastric and gej cancers
-
2:37
advancing neoadjuvant immunotherapy in dmmr deficient colon cancer
-
1:11
remaining questions for the treatment of patients with msi/dmmr mcrc with immunotherapy
-
3:26
infinty: tremelimumab and durvalumab in msi-high gc/gejc
-
13:38
neoadjuvant chemotherapy for gastric cancer patients
-
0:58
adherence & outcomes of neoadjuvant immunotherapy in resectable nsclc
-
1:07
the benefits and pitfalls of total neoadjuvant therapy in rectal cancer
-
1:04
the future of targeted therapies for advanced colorectal cancer
-
1:00
utilizing neoadjuvant immunotherapies in patients with er , her2- primary breast cancer
-
0:51
addressing resistance to icis in colorectal cancer